The rise of hyper‐virulence

Aschtgen, Marie‐Stéphanie; Henriques‐Normark, Birgitta; Normark, Staffan

doi:10.1111/joim.13018

Cited by 2 publications

(1 citation statement)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Moreover, recent studies have suggested an increased rate of MDR in hvKp species, previously identified predominantly in nosocomial cKp infections [ 110 , 111 ]. Thus, the CDC and the WHO declared such emerging MDR and hvKp infections as an urgent public health threat [ 112 , 113 , 114 ]. These infections may seriously complicate the course of COVID-19, especially in hvKp-endemic areas.…”

Section: Enterobacter Spp a Baumanni And...mentioning

confidence: 99%

Antibiotic-Resistant ESKAPE Pathogens and COVID-19: The Pandemic beyond the Pandemic

Catalano,

Iacopetta,

Ceramella

et al. 2023

Viruses

View full text Add to dashboard Cite

Antibacterial resistance is a renewed public health plague in modern times, and the COVID-19 pandemic has rekindled this problem. Changes in antibiotic prescribing behavior, misinformation, financial hardship, environmental impact, and governance gaps have generally enhanced the misuse and improper access to antibiotics during the COVID-19 pandemic. These determinants, intersected with antibacterial resistance in the current pandemic, may amplify the potential for a future antibacterial resistance pandemic. The occurrence of infections with multidrug-resistant (MDR), extensively drug-resistant (XDR), difficult-to-treat drug-resistant (DTR), carbapenem-resistant (CR), and pan-drug-resistant (PDR) bacteria is still increasing. The aim of this review is to highlight the state of the art of antibacterial resistance worldwide, focusing on the most important pathogens, namely Enterobacterales, Acinetobacter baumannii, and Klebsiella pneumoniae, and their resistance to the most common antibiotics.

show abstract

Section: Enterobacter Spp a Baumanni And...mentioning

confidence: 99%